Which of the following diagnostic studies would you anticipate being ordered on your patient with DIC?

Choice A rationale Prothrombin time and partial thromboplastin time are essential diagnostic tests for disseminated intravascular coagulation. These tests measure the extrinsic and intrinsic pathways of the coagulation cascade. In this condition, the massive consumption of clotting factors leads to a significant prolongation of these values. Normal prothrombin time is typically 11 to 13.5 seconds, and partial thromboplastin time is 25 to 35 seconds. Monitoring these helps clinicians understand the severity of the coagulopathy and the risk of spontaneous bleeding. Choice B rationale An electrocardiogram is used to assess the electrical activity of the heart and is vital for detecting arrhythmias or ischemia. While disseminated intravascular coagulation can lead to myocardial microthrombi and subsequent heart strain, an EKG is not a primary diagnostic tool for the hematologic disorder itself. It provides secondary information about organ damage rather than the status of the clotting and fibrinolytic systems. Therefore, it is not a specific test anticipated for the initial diagnosis of DIC. Choice C rationale D-dimer is a fibrin degradation product that is produced when cross linked fibrin is broken down by plasmin. In disseminated intravascular coagulation, there is simultaneous widespread clotting and fibrinolysis, leading to extremely high levels of D-dimer. A normal D-dimer level is generally less than 500 nanograms per milliliter. An elevated result is highly sensitive for the presence of intravascular thrombi and is a key laboratory finding used to confirm the diagnosis of this complex hematologic syndrome. Choice D rationale Urinalysis may show hematuria if the patient is bleeding from the renal tract due to the consumption of clotting factors, but it is not a definitive diagnostic study for disseminated intravascular coagulation. It is a supportive test that helps identify organ specific complications. The diagnosis relies on systemic markers of coagulation and fibrinolysis in the blood rather than findings in the urine. Therefore, while helpful for monitoring, it is not one of the primary tests used to define the condition.